Somatostatin Receptor Imaging in the Diagnosis and Management of Parathyroid Neuroendocrine Neoplasia

Somatostatin Receptor Imaging in the Diagnosis and Management of Parathyroid Neuroendocrine Neoplasia

Background: Parathyroid tumors are classified as parathyroid neuroendocrine neoplasia (NEN) by the IARC-WHO classification. These tumors can occur with NENs from other sites, which often require total-body [68Ga]-DOTA-peptides PET/CT. This study aimed to assess the utility of [68Ga]-DOTA-peptide PET...

Full description

Bibliographic Details
Main Authors: Uliana Tsoy, Karina Pogosian, Daria Ryzhkova, Olga Yudina, Ksenia Yakovenko, Pavel Ryazanov, Irina Matsueva, Polina Sokolnikova, Maksim Salov, Tatiana Karonova, Elena Grineva
Format: Article
Language:English
Published: MDPI AG 2024-12-01
Series:Diagnostics
Subjects:
parathyroid neuroendocrine neoplasms
parathyroid adenoma
somatostatin receptors type 2
somatostatin receptors type 5
PET/CT with 68Ga-DOTA-peptides
Online Access:https://www.mdpi.com/2075-4418/14/23/2718

Internet

https://www.mdpi.com/2075-4418/14/23/2718

Similar Items